top of page
The Professional Network for Healthcare Experts
Pelthos and Castle Creek agree biotechnology merger with up to $300 million in contingent milestone payments
Pelthos Therapeutics and Castle Creek Biosciences have agreed to merge, combining a dermatology portfolio with a fibroblast-based cell and gene therapy platform for serious skin diseases.
nuaxia
Nov 32 min read
Flagship Pioneering merges Cellarity, Etiome and Empress platforms to launch AI drug discovery company Etcelera
Flagship Pioneering has formed Etcelera by combining three biotechnology platforms with AI capabilities to develop a causal-intelligence approach to drug discovery.
nuaxia
Oct 302 min read
bottom of page